Evidence map›Paper›PMID 26537405›Full record

ReviewQuarterly reviews of biophysics2015

A sequence-specific DNA binding small molecule triggers the release of immunogenic signals and phagocytosis in a model of B-cell lymphoma.

JeenJoo S Kang, Peter B Dervan

Open access · hybridAbstract readReview
In one paragraph

Review in Quarterly reviews of biophysics, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

JeenJoo S KangDivision of Chemistry and Chemical Engineering,California Institute of Technology,Pasadena,CA 91125,USA.
Peter B DervanDivision of Chemistry and Chemical Engineering,California Institute of Technology,Pasadena,CA 91125,USA.
California Institute of Technology · US

Funding

SITE SPECIFIC CHEMICAL METHODS FOR CLEAVING GENOMIC DNAR01GM051747 · NIGMS · CALIFORNIA INSTITUTE OF TECHNOLOGY · PI DERVAN, PETER B · 1995 to 2014
$6.2M
SEQUENCE SPECIFIC RECOGNITION OF DOUBLE HELICAL DNAR01GM027681 · NIGMS · CALIFORNIA INSTITUTE OF TECHNOLOGY · PI DERVAN, PETER B · 1985 to 2017
$4.5M
NIGMS NIH HHS GM51747NIGMS NIH HHS R01 GM027681NIGMS NIH HHS R01 GM051747
6 · The paper itself

Abstract

Means to cause an immunogenic cell death could lead to significant insight into how cancer escapes immune control. In this study, we screened a library of five pyrrole-imidazole polyamides coding for different DNA sequences in a model of B-cell lymphoma for the upregulation of surface calreticulin, a pro-phagocytosis signal implicated in immunogenic cell death. We found that hairpin polyamide 1 triggers the release of the damage-associated molecular patterns calreticulin, ATP and HMGB1 in a slow necrotic-type cell death. Consistent with this signaling, we observed an increase in the rate of phagocytosis by macrophages after the cancer cells were exposed to polyamide 1. The DNA sequence preference of polyamide 1 is 5'-WGGGTW-3' (where W = A/T), indicated by the pairing rules and confirmed by the Bind-n-Seq method. The close correspondence of this sequence with the telomere-repeat sequence suggests a potential mechanism of action through ligand binding at the telomere. This study reveals a chemical means to trigger an inflammatory necrotic cell death in cancer cells.

Indexed as

PhagocytosisAdenosine TriphosphateAnimalsCalreticulinDNAEnzyme-Linked Immunosorbent AssayHMGB1 ProteinHumansImidazolesImmunoblottingInflammationK562 CellsLuminescenceLymphoma, B-CellMacrophagesNecrosisAdenosine TriphosphateCalreticulinDNAHMGB1 ProteinHMGB1 protein, humanImidazolesNylonsPyrrolesdamage-associated molecular patternsDNA-binding small moleculeimmunogenic cell deathnecrotic cell deathPy-Im Polyamidetelomere sequence

Identifiers

PMID26537405
PMCPMC4743504
OpenAlexW2105161308

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.